This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 1 of 5 for:    "Optic Atrophy, Autosomal Dominant" OR "optic atrophy type 1"
Previous Study | Return to List | Next Study

Advanced Characterization of Autosomal Dominant Optic Atrophy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2012 by Cecilia Rönnbäck, Glostrup University Hospital, Copenhagen.
Recruitment status was:  Enrolling by invitation
Sponsor:
Information provided by (Responsible Party):
Cecilia Rönnbäck, Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier:
NCT01522638
First received: November 30, 2011
Last updated: January 27, 2012
Last verified: January 2012
  Purpose
The purpose of this study is to determine the anatomy of the retina and the optic nerve in patients with autosomal dominant optic atrophy (ADOA). Based on these findings the aim of the study is to determine why patients with the same type of genetic material, i.e. the same mutation, have such large variations of symptoms, spanning from unaffected subjects to blindness. The project requires examination of both healthy and affected family members.

Condition
Optic Atrophy, Autosomal Dominant

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Cross-Sectional
Official Title: Cross Sectional Study of Autosomal Dominant Opticus Atrophy

Resource links provided by NLM:


Further study details as provided by Cecilia Rönnbäck, Glostrup University Hospital, Copenhagen:

Primary Outcome Measures:
  • visual acuity [ Time Frame: 1 day ]
  • vessel caliber [ Time Frame: 1 day ]
  • OCT [ Time Frame: 1 day ]
  • Microperimetry [ Time Frame: 1 day ]
  • Lifestyle questionnaire [ Time Frame: 1 day ]
  • General checkup [ Time Frame: 1 day ]

Estimated Enrollment: 50
Study Start Date: December 2011
Estimated Study Completion Date: June 2015
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
ADOA
This group includes subjects diagnosed with autosomal dominant optic atrophy
Healthy subjects

  Eligibility

Ages Eligible for Study:   8 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Subjects with autosomal dominant optic atrophy in Denmark.
Criteria

Inclusion Criteria:

  • Subjects diagnosed with autosomal dominant optic atrophy

Exclusion Criteria:

  • Age below 8 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01522638

Locations
Denmark
Copenhagen University, Glostrup Hospital
Copenhagen, Denmark, DK-2600
Sponsors and Collaborators
Glostrup University Hospital, Copenhagen
Investigators
Principal Investigator: Michael Larsen, MD, Prof. DMSc Glostrup University Hospital
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Cecilia Rönnbäck, MD, Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier: NCT01522638     History of Changes
Other Study ID Numbers: ADOA
Study First Received: November 30, 2011
Last Updated: January 27, 2012

Additional relevant MeSH terms:
Optic Atrophy, Autosomal Dominant
Atrophy
Optic Atrophy
Pathological Conditions, Anatomical
Optic Nerve Diseases
Cranial Nerve Diseases
Nervous System Diseases
Eye Diseases
Optic Atrophies, Hereditary
Heredodegenerative Disorders, Nervous System
Neurodegenerative Diseases
Eye Diseases, Hereditary
Genetic Diseases, Inborn
Mitochondrial Diseases
Metabolic Diseases

ClinicalTrials.gov processed this record on July 21, 2017